Effect of Combined Mycophenolate and Rapamycin Treatment on Kidney Fibrosis in Murine Lupus Nephritis

Background: A significant proportion of lupus nephritis patients develop chronic kidney disease (CKD) and progressive kidney fibrosis, for which there is no specific treatment. We previously reported that mycophenolate or rapamycin monotherapy showed comparable efficacy in suppressing kidney fibrosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chenzhu, Tam, Tsz Wai, Chau, Mel KM, García Córdoba, Cristina Alexandra, Yung, Susan, Chan, Tak Mao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095843/
https://www.ncbi.nlm.nih.gov/pubmed/35571122
http://dx.doi.org/10.3389/fphar.2022.866077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095843/
https://www.ncbi.nlm.nih.gov/pubmed/35571122
http://dx.doi.org/10.3389/fphar.2022.866077

Ejemplares similares